. 2020 Jan 27;10:3022. doi: 10.3389/fimmu.2019.03022

Table 4.

Clinical immunology results.

Patient ID	IgG^# (g/L)	IgM (g/L)	IgA (g/L)	Lymfocyte count (cells/μL WB)	B cells (CD19+; cells/μL)	NK cells (CD56+; cells/μL)	T cells (CD3+; cells/μL)	CD4 (cells/μL)	CD8 (cells/μL)	CD4/CD8-ratio	Isohaemagglutinin IgM/IgG
P1	2.9	<0.2	BD	881	63	29	774	290	435	0.67	NP
P2	2.9	0.32	BD	5,800	160	40	1,200	800	350	2.4	NP
P3	1.1	<0.2	BD	908	68	109	717	430	230	1.88	NP
P4	0.3	<0.2	BD	2,140	738	257	1,119	693	393	1.76	NP
P5	0.9	<0.2	BD	400	2	46	347	155	153	1.01	After IVIG/after IVIG
P6	^*	<0.2	BD	493	59	79	281	143	109	1.32	After IVIG/after IVIG
P7	^*	<0.2	BD	632	15	58	504	215	274	0.79	NP
P8	4.4	0.59	0.7	1,072	77	93	889	530	264	2.01	Normal
P9	^*	<0.2	BD	324	22	25	270	186	74	2.51	NP
P10	4.2	^*	BD	266	68	34	156	102	48	2.13	NP (only after IVIG)
P11	^*	<0.2	BD	1,147	92	203	848	240	522	0.46	NP
P12	3.3	0.3	BD	516	118	94	285	168	100	1.67	NP
P13	0.47	<0.2	BD	1,323	106	118	1,050	431	562	0.77	Absent A; decreased (B) (both IgM+IgG)
P14	^*	<0.2	BD	1,600	224	51	1,312	853	354	2.41	NP
P15	5.9	0.82	0.54	2,917	268	76	2,482	1,633	730	2.24	Decreased/decreased
P16	4.8	0.42	1.58	3,213	321	112	2,757	1,566	1,023	1.53	Decreased/decreased
P17	0.7	0.15	BD	1,877	135	139	1,541	925	564	1.64	Decreased/decreased
P18	2.2	1.12	0.13	5,113	1,089	547	3,288	1,772	1,065	1.66	Decreased/normal
P19	4.3	0.49	0.24	1,600	149	210	1,182	876	234	3.74	Decreased/decreased
P20	7.5	0.23	3.45	249	18	106	123	97	20	4.81	NP

No measurement available;

^#,

IgG before initiation of immunoglobulin substitution therapy; BD, below detection limit. Reference values: IgG_tot (6.9–15.7 g/L); IgM (g/L) (0.55–3.9); IgA (g/L) (BD; below detection limit) (0.8–3.9); Lymfocyte count (cell/μL WB) (1,000–2,800); B cells (CD19+; cells/μL) (70–272); NK cells (CD56+; cells/μL) (52–639); T cells (CD3+; cells/μL) (581–1,895); CD4 (cells/μL) (309–1,140); CD8 (cells/μL) (137–823); CD4/CD8-ratio (PMID: 14962239); NP, not performed; BD; below detection limit.